Connect with us

New Jersey

Experimental cancer treatment gives New Jersey mom a chance for a second baby: ‘I decided to go for it’

Published

on

Experimental cancer treatment gives New Jersey mom a chance for a second baby: ‘I decided to go for it’


A New Jersey mom had just given birth when she received a life-changing cancer diagnosis — and her biggest fear was she wouldn’t be able to have more children.

When Kelly Spill first started experiencing bleeding, her doctors chalked it up to pregnancy and childbirth, especially given her young age of 28.

But then came the weight loss, fatigue and loss of appetite. “I knew deep down that it was cancer,” she told Fox News Digital.

TRAGIC CANCER LOSS INSPIRES NEW YORK TECH ENTREPRENEUR TO ADDRESS ‘URGENT MEDICAL NEED’

Advertisement

After a colonoscopy, Spill’s fears were confirmed: She had stage 3 colorectal cancer

Her baby boy, Chase Bonito, was just a month old.

Kelly Spill of New Jersey was a new mom with a 1-month-old son (shown at left) when she was diagnosed with stage 3 colorectal cancer. (Kelly Spill)

The original plan was to check out three hospitals to get treatment options and gauge their level of comfort, she said.

The first stop, Memorial Sloan Kettering Cancer Center in New York, ended up being their last.

Advertisement

“They checked all the boxes,” Spill said.

“I would most likely never be able to carry another baby again.”

“The original plan was to get chemotherapy, radiation and surgery,” Spill told Fox News Digital. 

“But that would have meant I would most likely never be able to carry another baby again — and that’s really hard to hear at just 28 years old,” she said.

Cancer treatment and fertility

Traditional cancer treatments are known to impact a woman’s ability to have children, according to Amanda Schwer, M.D., a radiation oncologist at City of Hope Orange County Lennar Foundation Cancer Center in Irvine, California.

Advertisement

“Radiation targeted at, or absorbed by, a woman’s reproductive organs can affect fertility, as can chemotherapy, which may cause women to lose fertility-related hormones,” Schwer, who was not involved in Spill’s care, told Fox News Digital. 

Madhu Shetti, a radiation oncologist and founder of skincare company Balmere in California, noted that certain chemotherapy drugs can shift the hormone levels in a pre-menopausal woman into menopause, making it difficult to conceive a child.

The original plan was for Spill to have chemotherapy, radiation and surgery — which would have impacted her ability to have additional children. Spill is pictured here with her first child, a son named Chase Bonito. (Kelly Spill)

“Ultimately, every woman should speak with her care team to understand her individual risks, benefits and alternatives,” said Shetti, who did not treat Spill, in a statement to Fox News Digital.

An unexpected new treatment

Just before she scheduled her first day of chemo, Spill was presented with a new treatment path.

Advertisement

Based on her biopsies, doctors told Spill she was a match for a new clinical trial run by the SU2C Colorectal Cancer Dream Team, a research team at Memorial Sloan that is committed to improving access to alternative cancer care.

WHAT IS COLORECTAL CANCER? SIGNS, SYMPTOMS, RISKS AND MORE OF THE GLOBAL HEALTH CONCERN

The trial would test an immunotherapy drug — dostarlimab — as a first-line treatment in lieu of grueling rounds of chemo, radiation and surgery. 

“All I knew at that time was that the side effects of this immunotherapy would be a lot less harsh on my body than chemotherapy, and I would have a chance of a better quality of life — and maybe even another baby,” Spill said.

“We know that immunotherapy success rates may differ, and not every patient responds or has a lasting response to it.”

Advertisement

Immunotherapy works by activating the patient’s own immune system to attack the cancer cells, Schwer said. 

“It is an important cancer treatment breakthrough and there have been many advancements in this field,” she said. 

WHY IMMUNOTHERAPY IS EMERGING AS THE ‘FOURTH PILLAR’ OF CANCER TREATMENTS, EXPERTS SAY

“However, it is still evolving. We know that immunotherapy success rates may differ, and not every patient responds or has a lasting response to it.”

Age, lifestyle factors and other existing medical conditions can all impact the effectiveness of immunotherapy treatments, Schwer added. 

Advertisement

Spill, pictured with her son and husband, underwent immunotherapy infusions as an alternative to chemo and radiation. (Kelly Spill)

“Genetic testing may help detect treatments that are more effective for patients, but more research is still needed in this field.”

‘All about timing’

After talking with her care team and weighing the risks and potential benefits, Spill decided to proceed with the clinical trial.

“I decided to go for it. For me, it was all about timing.”

Spill was just the fourth person in the country to participate in the trial. 

Advertisement

She received dostarlimab via infusion every three weeks for six months.

“One of the hardest parts about cancer is coming out of survival mode, and realizing you’re a human again and taking on life again.”

Although side effects are a possibility with immunotherapy, Spill said she only experienced fatigue — “which sometimes I think it was mostly from motherhood.” 

At her fourth treatment, Spill was told that her tumor had shrunk in half. 

“By the ninth treatment, my tumor had completely disappeared, which was extremely exciting,” she said.

Advertisement

New chance at life

Before starting treatment, Spill and her husband had frozen some embryos as a safety measure. 

After she was declared cancer-free, her first desire was to become pregnant again.

PATIENTS WITH METASTATIC COLORECTAL CANCER COULD FIND HOPE IN NEW FDA-APPROVED TREATMENT

“But my doctor advised me to wait at least two years, because if the cancer was going to come back, it would most likely be in that time frame,” Spill said.

That was difficult for her to hear, she said — but now she sees it as a smart decision.

Advertisement

“One of the hardest parts about cancer is coming out of survival mode, and realizing you’re a human again and taking on life again,” Spill said.

During those two years of waiting, she took some emotional intelligence courses to help her process what she had been through.

“By the ninth treatment, my tumor had completely disappeared, which was extremely exciting,” Spill told Fox News Digital. (Kelly Spill)

“I came out a much better person than who I was prior,” Spill said.

In July 2023, she gave birth to her second child, a healthy baby girl.

Advertisement

“Her name is Maya Grace, and she’s an angel,” she told Fox News Digital.

IN POTENTIAL CANCER BREAKTHROUGH, NEWLY FOUND ‘KILL SWITCH’ TRIGGERS DEATH OF CANCER CELLS: ‘ONE-TWO PUNCH’

Today, Spill remains cancer-free. 

She has gone in for scans and biopsies every six months, and just got the approval to move to yearly scans. 

Spill said her son, pictured with his newborn sister, loves being a big brother. (Kelly Spill)

Advertisement

Spill and her husband are already talking about a third baby, she shared.

To others facing a new diagnosis, Spill’s advice is to “feel your feelings.”

“Feel anything that you are feeling at that time, because it’s important,” she said. 

“It helps you understand what you are going through.”

After she was declared cancer-free, Spill said her first desire was to become pregnant again, but doctors advised her to wait two years. She is pictured here with her son. (Kelly Spill)

Advertisement

Spill also emphasizes the importance of being your own advocate.

“You don’t like an answer? Keep searching. You know your body best.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Anyone who is interested in exploring immunotherapy should consult with their health care provider, experts advise.

“It is important to speak with your oncologist to understand your individual risks, benefits and alternatives,” said Shetti.

Advertisement

Spill, pictured with her daughter, remains cancer-free. She has gone in for scans and biopsies every six months, and just got the approval to move to yearly scans. (Kelly Spill)

Women who are considering having children should ask their provider about the potential impact of any treatment, added Schwer.

“If you are facing cancer, thinking about starting or growing a family right now can add to the sense of feeling overwhelmed,” she told Fox News Digital. 

CLICK HERE TO GET THE FOX NEWS APP

“Remember, you are not alone — and you will benefit from talking to your physician about your concerns and the fertility preservation options that are best for you.”

Advertisement

For more Health articles, visit www.foxnews.com/health.



Source link

Advertisement

New Jersey

Soaking rain, gusty winds looming in N.J. this weekend before cold air sweeps in

Published

on

Soaking rain, gusty winds looming in N.J. this weekend before cold air sweeps in


New Jersey residents can expect quiet conditions Thursday night before a warm front lifts northward, bringing increasing clouds and a chance of rain showers by Friday afternoon.

Temperatures are forecast to rise 10 to 15 degrees above normal, reaching the mid-50s, as a precursor to a wet start to the weekend.

The first round of precipitation is expected to arrive late Friday afternoon into the early evening hours. While rainfall is generally expected to be light during this initial phase, there could be an isolated rumble of thunder, according to forecasters from the National Weather Service.

A cold front will pass through the region overnight, likely creating a lull in the rain showers before the next system arrives.

Advertisement

More widespread rainfall is forecast to return Saturday afternoon and evening as low pressure tracks across the area. During this time, rain could become heavy at times.

Rainfall totals between a half inch and 1.5 inches are predicted across New Jersey through Saturday night. Despite the anticipated volume of water, forecasters say flooding risks should be minimal to none.

Due to the recent stretch of mild temperatures, there is no concern regarding ice jams or river ice hindering runoff.

Temperatures will remain warm for January in New Jersey through the weekend, but heavy rain is expected Friday night into Saturday.National Weather Service

There is some uncertainty in the forecast regarding specific temperatures and wind speeds for Saturday, the weather service said.

Conditions will change significantly on Sunday as a secondary cold front moves through the region, forecasters said. As the rain clears, strong cold air advection will result in a breezy day, with west to northwest wind gusts peaking in the 30 to 40 mph range.

Advertisement

Temperatures will drop throughout the day, falling into the 20s for most of the area by Sunday night.

Looking ahead to the start of the work week, high pressure will build over the region, bringing dry conditions. Monday and Tuesday are expected to feature clear skies and temperatures near normal for January.

By Tuesday and Wednesday, return flow will develop as high pressure moves off the coast, helping temperatures moderate to about 5 degrees above normal.

No significant weather impacts are expected from Monday through next Thursday.

Current weather radar



Source link

Advertisement
Continue Reading

New Jersey

Family grieving after deadly wrong-way crash in Totowa, New Jersey

Published

on

Family grieving after deadly wrong-way crash in Totowa, New Jersey


Two people were killed and two others, including a toddler, were injured in a wrong-way crash in Totowa, New Jersey, earlier this week.

Officials confirm the wrong-way driver was off-duty Newark firefighter Albin Fermin, 30. According to Newark officials, Fermin had been with the Newark Fire Department since February 2024 and was assigned to Engine 10.

Wrong-way driver, mother of 2-year-old killed

The crash happened on I-80 just after 2 a.m. Monday.

New Jersey State Police said 60-year-old Joanne Furman was driving west on I-80 with her daughter Imani Furman, 24, and her 2-year-old grandson, when they were struck head-on by Fermin, who was driving the wrong way.

Advertisement

Fermin and Imani Furman were both killed in the crash.

Police said Joanne Furman was seriously injured and the 2-year-old suffered moderate injuries. Both were taken to a local hospital.

The crash remains under investigation.

Imani Furman and her 2-year-old son, Messiah

Advertisement

Photo provided


“It wasn’t my daughter’s fault”

Janice Furman, Joanne Furman’s mother and Imani Furman’s grandmother, said her family is devastated.

“It wasn’t my daughter’s fault. It was not her fault,” she said. “They’re showing pictures of [Fermin], his family and the whole team of his fire department. ‘We’re going to miss you.’ Almost like a heroic thing. This isn’t heroic. He killed someone.”

Janice Furman said after undergoing several surgeries, Joanne Furman regained consciousness Wednesday. That’s when the family had to break the news about Imani Furman.

“That’s all she said to me, is, ‘Mommy, she’s gone,’” Janice Furman said.

Advertisement

She said the family is overwhelmed with grief.

“Imani was a very spirit-filled young lady. She loved life. She loved to sing. She loved to dance,” Janice Furman said.

She said Imani Furman’s only son, Messiah, was her world.

“She won’t see him graduate. She won’t see anything,” Janice Furman said. 

Joanne Furman will have to undergo weeks of physical therapy before she can walk again, her mother said. The family is asking for prayers as they navigate her recovery and plan a funeral.

Advertisement



Source link

Advertisement
Continue Reading

New Jersey

Sherrill Announces that Lisa Asare will Continue as President and CEO of the NJ Maternal & Infant Health Innovation Authority  – Insider NJ

Published

on

Sherrill Announces that Lisa Asare will Continue as President and CEO of the NJ Maternal & Infant Health Innovation Authority  – Insider NJ


Governor-elect Mikie Sherrill today announced that Lisa Asare will continue as the President and CEO of the NJ Maternal & Infant Health Innovation Authority, and the position will remain in the Gov.-elect’s cabinet. Lisa Asare brings a depth of experience to the role, having held previous positions as Deputy Commissioner of Health Services within the New Jersey Department of Human Services and as Assistant Commissioner of the Division of Family Health Services at the New Jersey Department of Health.

“I have asked Lisa Asare to continue her strong leadership at NJ Maternal & Infant Health Innovation Authority as New Jersey continues to confront the Black Maternal Health crisis. She is known for her ability to bring state government together with practitioners, community partners, and local advocates to develop solutions that improve affordable access to care and health outcomes for women. Together, we’ll invest in programs that build the midwife and doula workforce, and leverage telehealth and remote monitoring services, both during and after pregnancy, to support postpartum moms and healthy infants,” said Governor-elect Mikie Sherrill.

“I am honored to continue to lead the NJ Maternal & Infant Health Innovation Authority. At MIHIA, we are focused not only on delivering physical care, but addressing the social determinants of health, expanding the perinatal workforce, supporting research and data collection, and acting as an incubator for innovation in maternal and infant health. I’m looking forward to continuing to advance this work as part of the Sherrill-Caldwell administration because I know the Governor-elect is committed to these same goals and has already demonstrated that community members have a seat at the table as we work to address healthcare disparities for communities of color across the state,” said Lisa Asare.

Governor-elect Sherrill highlighted the need to address maternal healthcare disparities throughout her campaign for governor and is committed to delivering on those promises. She sat down with moms, providers, community leaders, and advocates at roundtables across the state to pinpoint the key issues state government must address. Specifically, the Sherrill-Caldwell administration will work to build a culturally competent workforce, including doulas and nurse midwives, and ensure that students of color have access to these training programs. Additionally, the administration plans to invest in telehealth services, remote monitoring, and home visiting programs immediately after pregnancy to support postpartum outcomes and healthy infants.

Advertisement

Lisa Asare is the President and Chief Executive Officer of the NJ Maternal and Infant Health Innovation Authority, a position she was appointed to in March 2024. Prior to this appointment, Ms. Asare served as Deputy Commissioner of Health Services within the New Jersey Department of Human Services. In this role, she oversaw the Division of Medical Assistance and Health Services that administers NJ FamilyCare and the Division of Mental Health and Addiction Services. She also served as the Department lead on First Lady Murphy’s Nurture NJ maternal health initiative.

Ms. Asare previously worked as the Assistant Commissioner of the Division of Family Health Services at the New Jersey Department of Health, for more than 20 years. She redesigned the Division’s approach to addressing black infant mortality and maternal mortality, contributed to the NurtureNJ strategic plan, addressed the social determinants of health by collaborating with other state agencies and non-traditional partners, and leveraged additional state, federal, and philanthropic funding to address emerging issues and the COVID-19 pandemic.



Source link

Continue Reading

Trending